MOTS-c 10 mg + SS-31 10 mg Bundle

For decades, mitochondria were viewed primarily as energy-producing organelles. Advances in genomics later revealed that the mitochondrial genome encodes bioactive peptides capable of regulating systemic physiology. MOTS-c was identified within the 12S rRNA region of mitochondrial DNA as one of the first peptides shown to function as a circulating metabolic signal.

Subsequent studies demonstrated that MOTS-c is expressed across multiple tissues and can translocate to the nucleus in response to metabolic or oxidative stress. Its levels decline with aging, while exercise and metabolic challenges are associated with increased expression, suggesting a role in adaptive signalling.

This positioning at the intersection of mitochondrial biology, metabolic regulation, and aging research has made MOTS-c a peptide of considerable interest in laboratory investigations of energy homeostasis and cellular stress adaptation.

Mitochondria are the primary energy-producing organelles within cells and play a central role in oxidative phosphorylation, redox balance, and apoptotic signaling. Disruption of mitochondrial structure, cardiolipin composition, or cristae organization impairs electron transport efficiency, reduces ATP output, and increases oxidative stress. These features are commonly observed in cardiovascular research models, neurodegeneration research, renal cellular-stress models, and age-related functional decline.

SS-31 was developed at the Szeto-Schiller laboratory to directly address these mitochondrial vulnerabilities. Its aromatic, positively charged structure enables rapid cellular uptake independent of receptor binding, with selective concentration in the inner mitochondrial membrane. There it binds cardiolipin, a unique tetra-acyl phospholipid required for cristae formation and respiratory chain supercomplex assembly.

This structural mode of action distinguishes SS-31 from conventional antioxidants and positions it as a frequently used research tool in mitochondrial biology, bioenergetics, and laboratory investigations of energy homeostasis and cellular stress adaptation.

1. Activation of AMPK Signaling

MOTS-c promotes cellular energy balance by activating the AICAR-AMPK pathway. This activation enhances glucose uptake, suppresses excessive gluconeogenesis, and increases fatty acid oxidation. Through these mechanisms, MOTS-c supports stable glucose homeostasis and improves insulin responsiveness.

2. Regulation of Nuclear Gene Expression

Under stress conditions, MOTS-c can enter the nucleus and interact with transcription factors involved in metabolic and inflammatory regulation. By influencing gene networks linked to glucose transport, mitochondrial biogenesis, and immune modulation, it acts as a messenger coordinating mitochondrial and nuclear responses.

3. Mitochondrial Remodeling and Stress Resistance

MOTS-c modulates mitochondrial dynamics by promoting fusion processes and regulating biogenesis-associated proteins. These changes enhance mitochondrial efficiency while limiting oxidative damage. Concurrently, MOTS-c upregulates antioxidant defenses, reducing reactive oxygen species and protecting cellular integrity.

4. Musculoskeletal and Endothelial Modulation

MOTS-c influences muscle differentiation and bone remodeling by regulating osteoblast and osteoclast activity, while also improving vascular endothelial performance and reducing inflammatory signaling in cardiac tissue under metabolic stress models.

Research Applications

Conclusion

MOTS-c represents a unique class of mitochondria-encoded peptides that function as systemic metabolic regulators. By integrating mitochondrial signaling with nuclear gene control, MOTS-c supports energy homeostasis, stress resistance, and age-related metabolic adaptation. Its diverse biological actions make it a valuable research target in metabolism, aging, and mitochondrial biology.

1. Selective Cardiolipin Binding

SS-31 concentrates in the inner mitochondrial membrane through high-affinity interaction with cardiolipin. This binding stabilizes the cardiolipin-cytochrome c complex, supports cristae curvature, and preserves the organization of respiratory chain supercomplexes essential for efficient electron transport.

2. Reduction of Mitochondrial Oxidative Stress

By stabilizing the cardiolipin-cytochrome c interaction, SS-31 limits cytochrome c peroxidase activity, a key driver of cardiolipin peroxidation. This action reduces electron leakage from the respiratory chain and lowers reactive oxygen species generation at the source of mitochondrial oxidant production.

3. Preservation of ATP Synthesis

Maintained cristae architecture and protected supercomplex organization support efficient proton gradient formation and ATP synthase function. SS-31 has been shown to preserve mitochondrial respiration and ATP output in cellular and tissue models exposed to ischemic or metabolic stress.

4. Support of Mitochondrial Quality Control

Research indicates that SS-31 influences mitochondrial dynamics by promoting fusion processes, limiting excessive fission, and supporting mitophagy of damaged mitochondria. These actions contribute to long-term mitochondrial quality control in high-energy-demand tissues.

Research Applications

Conclusion

SS-31 represents a structurally targeted approach to mitochondrial research, acting through selective cardiolipin binding rather than non-specific radical scavenging. By preserving cristae architecture, supporting respiratory chain organization, and limiting cardiolipin peroxidation, SS-31 supports stable mitochondrial bioenergetics across cardiac, renal, neuronal, and aging research models. Its mechanistic specificity makes it a valuable reference compound in mitochondrial biology and bioenergetic research.